ArticleAnnals of dermatology2018

An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO® (Retapamulin) Administered in Korean Patients According to the Prescribing Information.

Woosung Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.